Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Raquel Andreu Vilarroig

Raquel Andreu Vilarroig

Institutions of which they are part

Research technician
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca
Raquel Andreu Vilarroig

Raquel Andreu Vilarroig

Raquel Andreu Vilarroig

Institutions of which they are part

Research technician
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Projects

Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders

IP: Lucas Moreno Martín-Retortillo
Collaborators: Luís Gros Subias, Raquel Andreu Vilarroig, Andrea Vilaplana Blanes, Pablo Velasco Puyó, Laura Murillo Sanjuán, Maria Isabel Benitez Carabante, Aroa Soriano Fernández, Guillem Pons Barcons, Jose Miguel Lizcano De Vega, Maria Cristina Díaz de Heredia Rubio, Maria Luz Uría Oficialdegui, Maria Jose Pérez García, Miguel Segura Ginard, M Mar Mañu Pereira, Lorena Valero Arrese, Thaïs Murciano Carrillo, Constantino Sábado Álvarez, Anna Llort Sales, Raquel Hladun Alvaro, Carlota Aguilera Ordoñez, Adria Molero Valenzuela, Júlia Sansa Girona, Gabriela Guillén Burrieza, Laura Alonso Garcia, Idoia Bolinaga Ayala, Josep Roma Castanyer, Sergio Espinosa Gil, Elena Andretta, Claire Diot, Amira Idrizovic
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00638
Duration: 01/01/2022 - 30/06/2025

Related news

ERN-EuroBloodNet

Vall d'Hebron leads the analysis of COVID-19 in rare hematological diseases

The study analyzes the impact of COVID-19 on people with rare red blood cell disorders, identifying risk factors for severe forms of the disease.

Entrega xec Mi compañero de viaje

Mi Compañero de Viaje adds a decade of donations in the fight against cancer

The association, once again, has shown its commitment to oncological research with a donation of €19,197 to the Cancer and Hematological Diseases Group for Children at VHIR.

Equip del grup de Càncer i Malalties Hematològiques Infantils del VHIR

A study demonstrates the effectiveness of gene therapy in patients with Fanconi anemia

The prestigious journal The Lancet has published the results of this study, which is the result of more than 20 years of pre-clinical research and 7 years of patient follow-up.

See more

Related professionals

Cristina Avila Fumanal

Cristina Avila Fumanal

Growth and Development
Read more
Mireia Beltran Porres

Mireia Beltran Porres

Growth and Development
Read more
Laia Closa Gil

Laia Closa Gil

Postdoctoral researcher
Transfusional Medicine
Read more
Sandra Rojas Nieto

Sandra Rojas Nieto

Shock, Organ Dysfunction and Resuscitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.